doravirine, a novel NNRTI, selects for specific mutations in vitro, including mutations at reverse transcriptase (RT) positions 106, 108, 188, 227, 230 and 234. the aim of this study was to examine the prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients.

Soulie, C., Santoro, M.m., Storto, A., Abdi, B., Charpentier, C., Armenia, D., et al. (2020). Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [10.1093/jac/dkz553].

Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy

Santoro, Maria Mercedes;Andreoni, Massimo;Perno, Carlo Federico;Ceccherini-Silberstein, Francesca;
2020-01-24

Abstract

doravirine, a novel NNRTI, selects for specific mutations in vitro, including mutations at reverse transcriptase (RT) positions 106, 108, 188, 227, 230 and 234. the aim of this study was to examine the prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients.
24-gen-2020
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/17 - MALATTIE INFETTIVE
Settore MED/07
Settore MEDS-03/A - Microbiologia e microbiologia clinica
Settore MEDS-10/B - Malattie infettive
English
Soulie, C., Santoro, M.m., Storto, A., Abdi, B., Charpentier, C., Armenia, D., et al. (2020). Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [10.1093/jac/dkz553].
Soulie, C; Santoro, Mm; Storto, A; Abdi, B; Charpentier, C; Armenia, D; Jary, A; Forbici, F; Bertoli, A; Gennari, W; Andreoni, M; Mussini, C; Antinori...espandi
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
dkz553.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 205.15 kB
Formato Adobe PDF
205.15 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/233895
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 21
social impact